This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Transcervical resection of endometrium versus medical Rx

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

There is evidence that in women with heavy menstrual bleeding, transcervical resection of endometrium (TCRE) provides better patient satisfaction and symptom relief than medical treatment.

This evidence is based on a randomised, unblinded, controlled trial with a 2-year follow-up.

  • study population was 187 patients who were consulted a consultant for the first time with heavy menstrual bleeding. The patients had a diagnosis of dysfunctional uterine bleeding, had not been referred for surgery, did not wish to have further children and did not have a preference regarding treatment
  • 93 woman were allocated to TCRE and 94 to medical management. Medical treatments used consisted of the combined oral contraceptive pill, progestogens, danazol, tranexamic acid, non-steroidal anti-inflammatory drugs and hormone replacement therapy
  • the study was analysed by intention to treat. Less women in the TCRE group had heavier or unchanged menstrual bleeding or required additional treatments. Also more women in the TCRE group were cured or had an acceptable improvement in their symptoms (p=0.0017), were satisfied with their treatment (p=0.002) and rated their treatment as acceptable (p=0.004) than the medical management group

Reference:

  • Br J Obset Gynaecol (1999), 106, 258-65.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.